resTORbio Announces Additional RTB101 Phase 2b Data Demonstrating Decreased Incidence of Laboratory-Confirmed RTIs with Severe Symptoms, Total Infections and UTIs
RESTORBIO (TORC)
Last restorbio earnings: 3/12 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.restorbio.com/investor-resources/investor-faqi
Company Research
Source: GlobeNewswire
RTB101 10 mg once daily decreased incidence of laboratory-confirmed respiratory tract infections (RTIs) with severe symptoms by 52.1% vs. placebo (p=0.034) In addition to decreasing the incidence of laboratory-confirmed RTIs by 30.6% vs. placebo (p=0.025), RTB101 10 mg once daily decreased incidence of total infections of any kind by 23.6% vs. placebo (p=0.032) RTB101 10 mg twice daily and once daily decreased incidence of urinary tract infections (UTIs) by 74.6% (p=0.027) and 34.4% (p=0.156), respectively, vs. placebo Company expects to initiate pivotal Phase 3 program with RTB101 10 mg once daily in RTIs in 1H19 BOSTON, Oct. 16, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC) today announced additional positive results from its dose-ranging Phase 2b clinical trial of RTB101, an oral, selective and potent inhibitor of target of rapamycin complex 1 (TORC1), in respiratory tract infections (RTIs), as well as results from pre-specified analyses for any infection and urinar
Show less
Read more
Impact Snapshot
Event Time:
TORC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TORC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TORC alerts
High impacting RESTORBIO news events
Weekly update
A roundup of the hottest topics